[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100410712":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":17,"locations":23,"responsibleParty":40,"collaborators":7,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":44,"sex":48,"minAge":49,"maxAge":7,"enrollmentInfo":50,"targetDuration":53,"studyType":54,"phases":7,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Insel Gruppe AG, University Hospital Bern","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Use of echocardiography guidance for LAAC","Since August 2015, the echocardiography is routinely used by majority of operators to guide LAAC",[13],{"name":14,"affiliation":15,"role":16},"Lorenz Räber, Prof.","Insel Gruppe AG, Inselspital, Universitätsklinik für Kardiologie","PRINCIPAL_INVESTIGATOR",[18],{"name":14,"role":19,"phone":20,"phoneExt":21,"email":22},"CONTACT","31 632 09 29","+41","lorenz.raeber@insel.ch",[24],{"facility":25,"status":26,"city":27,"state":7,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Bern University Hospital Inselspital","RECRUITING","Bern","3010","Switzerland","CH",{"type":32,"coordinates":33},"Point",[34,35],7.44744,46.94809,{"lat":35,"lon":34},[38],{"name":14,"role":19,"phone":39,"phoneExt":7,"email":22},"+41 31 632 09 29",{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100410712","laac-registry-clinical-outcome-after-echocardiography-guided-laa-closure-100410712",false,"NCT04628078","LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure","Inclusion Criteria:\n\n* Age\\> 18\n* Written informed consent to participate in the study\n* Patients with paroxysmal, persistent, or permanent non-valvular AF and CHA2DS2-VASc Score of ≥2 that are planned for an elective LAA-closure\n* Anatomic characteristics allow placement of a CE marked device, dedicated for LAAC\n\nExclusion Criteria:\n\n* None. Considering the nature of the project, which is to prospectively collect information on all patients treated with LAAC in our center, we will only exclude patients unwilling to sign the informed consent.","ALL","18 Years",{"count":51,"type":52},1000,"ESTIMATED","5 Years","OBSERVATIONAL","The study aims at comparing, in a large cohort of consecutive clinically indicated left atrial appendage closure, clinical and imaging outcomes between different subpopulations.",[57,58,59],"Atrial Fibrillation","Cardiovascular Diseases","Thromboembolism",[61,62,63,64,65,66,67,68,69,70],"Left atrial appendage closure","Amulet","Watchman","Watchman flx","Acp","Cardiac computed tomography angiography","Transesophageal echocardiography","Peridevice leak","Thromboembolic events","Atrial fibrillation","2023-02-21",{"date":73,"type":74},"2023-02-22","ACTUAL",{"date":76,"type":74},"2015-08-12",{"date":78,"type":52},"2027-06-01",{"name":5,"class":6},1]